ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,735Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 950

$507K Total Retail Price of All Prescriptions

Rank: 40 out of 950

510 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 510 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 510 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 7,168 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $80 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 398 258 1 1
AMLODIPINE BESYLATE 376 326 2 5
HYDROCODONE-ACETAMINOPHEN 362 140 S3 3 6
FUROSEMIDE 285 223 4 9
ALLOPURINOL 230 162 5 52
LEVOTHYROXINE SODIUM 193 168 6 4
SIMVASTATIN 193 139 6 2
METOPROLOL TARTRATE 175 147 8 10
LISINOPRIL 148 118 9 3
METFORMIN HCL 147 103 10 7
WARFARIN SODIUM 140 125 11 14
ATENOLOL 139 133 12 15
ATORVASTATIN CALCIUM 133 116 13 12
METOPROLOL SUCCINATE 131 110 14 13
ZOLPIDEM TARTRATE 130 68 15 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 124 95 16 40
GABAPENTIN 123 58 17 18
AMITRIPTYLINE HCL 107 73 R 18 131
LOVASTATIN 104 81 19 44
TRAMADOL HCL 98 69 20 24
TAMSULOSIN HCL 93 78 21 11
HYDROCHLOROTHIAZIDE 88 66 22 8
MIRTAZAPINE 86 78 23 77
SYNTHROID 84 70 24 50
PANTOPRAZOLE SODIUM 83 81 25 55
CITALOPRAM HBR 80 75 26 27
SPIRONOLACTONE 79 55 27 132
NEXIUM 79 56 27 17
MELOXICAM 79 68 27 31
CYMBALTA 75 33 30 65
DIOVAN HCT 75 69 30 76
DILTIAZEM 24HR ER 75 72 30 173
PRAVASTATIN SODIUM 73 67 33 19
FAMOTIDINE 73 48 33 84
TRIAMTERENE-HCTZ 70 66 35 167
POTASSIUM CHLORIDE 68 49 36 53
DIOVAN 68 52 36 33
ISOSORBIDE MONONITRATE ER 67 39 38 78
SERTRALINE HCL 67 56 38 32
METHYLPREDNISOLONE 67 46 38 211
CLOPIDOGREL 66 53 41 26
CARVEDILOL 65 46 42 34
AZITHROMYCIN 64 43 43 38
BISOPROLOL-HYDROCHLOROTHIAZIDE 64 56 43 280
DIGOXIN 63 61 45 103
QUINAPRIL HCL 63 36 45 205
BUMETANIDE 61 44 47 286
GLYBURIDE-METFORMIN HCL 61 58 R 47 149
SPIRIVA 59 59 49 37
GLYBURIDE 59 40 R 49 89
CELEBREX 58 45 51 110
LYRICA 58 46 51 88
CARISOPRODOL 54 19 R 53 151
PREDNISONE 53 43 54 30
CLONIDINE HCL 50 37 55 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 28, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.